Cyclophosphamide injection in Tier 3 shortage across all Canadian suppliers

Health Canada declared a Tier 3 (most serious) shortage of cyclophosphamide for injection on Feb 20, 2026, with all three Canadian suppliers (Baxter, Sterimax, Andone) short across multiple vial sizes, mitigated via exceptional importation of foreign-labelled product and expected to continue into spring 2026. As a hospital/oncology-administered injectable, community pharmacies are unlikely to dispense it directly but may field patient questions about oncology/auto-immune supply.

ScopeUp summarizes Ontario practice updates and links every item to its official source. Verify details against the source document before changing workflows.